In vitro effects of dexamethasone on human corneal keratocytes

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 6, 1999, Pages 1061-1070

  Bourcier, Tristan ^a,b   Borderie, Vincent ^a   Forgez, Patricia ^b   Lombet, Alain ^b   Rostène, William ^b   Laroche, Laurent ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MIFEPRISTONE; MONOCLONAL ANTIBODY;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CORNEA CELL; DRUG EFFECT; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CORNEA; DEXAMETHASONE; GLUCOCORTICOIDS; HORMONE ANTAGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; MIFEPRISTONE; OSMOLAR CONCENTRATION; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0032954808     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Marques EF, Leite EB, Cunha-Vaz JG. Corticosteroids for reversal of myopic regression after photorefractive keratectomy. J Refract Surg. 1995;11:S302-S308.
2. Polack FM, Rosen PN. Topical steroids and tritiated thymidine uptake. Arch Ophthalmol. 1967;77:400-404.
3. Waterbury L, Kunysz EA, Beuerman R. Effects of steroidal and non-steroidal anti-inflammatory agents on corneal wound healing. J Ocul Pharmacol. 1987;3:43-54.
4. Srinivasan BD, Kulkarni PS. The effect of steroidal and nonsteroidal anti-inflammatory agents on corneal re-epithelialization. Invest Ophthalmol Vis Sci. 1981;20:688-691.
5. Park SC, Kim JH. Effect of steroids and nonsteroidal anti-inflammatory agents on stromal wound healing following excimer laser keratectomy in rabbits. Ophthalmic Surg Lasers. 1996;27:481-486.
6. Sugar A, Borosky JE, Meyer RF. A randomised trial of topical corticosteroids in epithelial healing after keratoplasty. Cornea. 1984;3:268-271.
7. Rask R, Koch Jensen P, Ehlers N. Healing velocity of corneal epithelium evaluated by computer. The effect of topical steroid. Acta Ophthalmol Scand. 1995;73:162-165.
8. Lu KL, Wee WR, Sakamoto T, McDonnell PJ. Comparison of in vitro antiproliferative effects of steroids and nonsteroidal antiinflammatory drugs on human keratocytes. Cornea. 1996;15:185-190.
9. Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease: cell culture evaluation. Arch Ophthalmol. 1984;102:598-604.
10. Fiscella R, Peyman GA, Elvart J, Yue B. In vitro evaluation of cellular inhibitory potential of various antineoplastic drugs and dexamethasone. Ophthalmic Surg. 1985;16:247-249.
11. Nguyen KD, Lee DA. Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast. Invest Ophthalmol Vis Sci. 1992;33:2693-2701.
12. Distelhorst CW. Glucocorticoid-induced apoptosis. Adv Pharmacol. 1997;41:247-270.
13. Wilson SE, Kim WJ. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 1998;39:220-226.
14. Helena MC, Baerveldt F, Kim WJ, Wilson SE. Keratocyte apoptosis after corneal surgery. Invest Ophthalmol Vis Sci. 1998;39:276-283.
15. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835-839.
16. Borderie VM, Lopez M, Lombet A, et al. Cryopreservation and culture of human corneal keratocytes. Invest Ophthalmol Vis Sci. 1998;39:1511-1519.
17. Ruedl C, Cappelletti V, Coradini D, Granata G, Di Fronzo G. Influence of culture conditions on the oestrogenic cell growth stimulation of human breast cancer cells. J Steroid Biochem Mol Biol. 1990;37:195-200.
18. Cadepond F, Ulmann A, Baulieu EE. RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med. 1997;48:129-156.
19. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18:5294-5299.
20. Wilson SE, Lloyd SA, He YG, McCash CS. Extended life of human corneal endothelial cells transfected with the SV40 large T antigen. Invest Ophthalmol Vis Sci. 1993;34:2112-2123.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
22. Trapp T, Rupprecht R, Castren M, Reul JM, Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron. 1994;13:1457-1462.
23. Cell Titer 96 Aqueous Non-radioactive Cell Proliferation Assay. Technical Bulletin 169. Madison, WI: Promega Corporation, 1994.
24. Hollenberg SM, Weinbeiger C, Hong ES, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 1985;318:635-641.
25. Boxen I, Tevaarwerk GJ. Charcoal as a phase separating agent in ligand assays: mechanism of action and the effect of dextran and various protein on the adsorption of small molecules. J Immunoassay. 1982;3:53-72.
26. He S, Wang HM, Ye J, Ogden TE, Ryan SJ, Hinton DR. Dexamethasone induced proliferation of cultured retinal pigment epithelial cells. Curr Eye Res. 1994;13:257-261.
27. Shimoyama M, Shimmura S, Tsubota K, Oguchi Y. Suppression of nuclear factor kappa B and CD18-mediated leukocyte adhesion to the corneal endothelium by dexamethasone. Invest Ophthalmol Vis Sci. 1997;38:2427-2431.
28. Lin MT, Eiferman RA, Wittliff JL. Demonstration of specific glucocorticoid binding sites in bovine cornea. Exp Eye Res. 1984;38: 333-339.
29. Cheeks L, Green K. Distribution of a steroid antagonist in the eye following topical administration. Curr Eye Res. 1986;5:705-709.
30. Southren AL, Dominguez MO, Gordon GG, et al. Nuclear translocation of the cytoplasmic glucocorticoid receptor in the irisciliary body and adjacent corneoscleral tissue of the rabbit following topical administration of various glucocorticoids: a rapid screening method for glucocorticoid activity. Invest Ophthalmol Vis Sci. 1983;24:147-152.
31. Guizani L, Perrin-Wolff M, Breard J, Binetruy B, Bertoglio J. Mechanisms in interleukin-2 protection against glucocorticoid-induced apoptosis: regulation of AP-1 and glucocorticoid receptor transcriptional activities. J Interferon Cytokine Res. 1996;16:601-609.
32. Fenz Z, Marti A, Jehn B, Altermatt HJ, Chicaiza G, Jaggi R. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J Cell Biol. 1995;131: 1095-1103.
33. Yamamoto M, Fukuda K, Miura N, Suzuki R, Kido, Komatsu Y. Inhibition by dexamethasone of transforming growth factor beta 1-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction. Hepatology. 1998;27:959-966.
34. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activity. Nature. 1980;284: 555-556.
35. Wilson SE, He YG, Weng J, et al. Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res. 1996;62:325-338.
36. Wilson SE. Molecular cell biology for the refractive corneal surgeon: programmed cell death and wound healing. J Refract Surg. 1997;13:171-175.
37. Hanna KD, Pouliquen YM, Waring GO III, Savoldelli M, Fantes F, Thompson KP. Corneal wound healing in monkeys after repeated excimer laser photorefractive keratectomy. Arch Ophthalmol. 1992;110:1286-1291.
38. Chung JH, Park YK, Lee JS, Kim WH. Effect of 0.1% dexamethasone on expression of stromal collagen type I and IV mRNA during the repair process of corneal alkali wounds [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4):S755. Abstract nr 3482.
39. Tzung SP, Fausto N, Hockenbery DM. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol. 1997;150:1985-1995.
40. Trautwein C, Rakemann T, Malek NP, Plumpe J, Tiegs G, Manns MP. Concanavalin A-induced liver injury triggers hepatocyte proliferation. J Clin Invest. 1998;101.1960-1969.
41. Dicken ES, Miesfeld RL. Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis. Mol Cell Biol. 1992;12:589-597.